BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2574740)

  • 1. Aspartate-releasing nerve terminals in rat striatum possess D-2 dopamine receptors mediating inhibition of release.
    Maura G; Carbone R; Raiteri M
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1142-6. PubMed ID: 2574740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-2 dopamine receptors inhibit release of aspartate and glutamate in rat retina.
    Kamisaki Y; Hamahashi T; Mita C; Itoh T
    J Pharmacol Exp Ther; 1991 Feb; 256(2):634-8. PubMed ID: 1671598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals.
    Maura G; Giardi A; Raiteri M
    J Pharmacol Exp Ther; 1988 Nov; 247(2):680-4. PubMed ID: 2903237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biphasic modulation of evoked [3H]D-aspartate release by D-2 dopamine receptors in rat striatal slices.
    Peris J; Dwoskin LP; Zahniser NR
    Synapse; 1988; 2(4):450-6. PubMed ID: 2973144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust modulation of [3H]dopamine release from rat striatal slices by D-2 dopamine receptors.
    Dwoskin LP; Zahniser NR
    J Pharmacol Exp Ther; 1986 Nov; 239(2):442-53. PubMed ID: 3772803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminals.
    Hoffmann IS; Talmaciu RK; Ferro CP; Cubeddu LX
    J Pharmacol Exp Ther; 1988 Jun; 245(3):761-72. PubMed ID: 3385641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the Ca++-evoked release of [3H]dopamine from striatal synaptosomes by dopamine (D2) agonists and antagonists.
    Bowyer JF; Weiner N
    J Pharmacol Exp Ther; 1987 Apr; 241(1):27-33. PubMed ID: 3572788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine-glutamate interaction in rat striatal slices: changes of CCDPK II, PKA, and LDH activity by receptor-mediated mechanisms.
    Tang FM; Sun YF; Wang R; Ding YM; Zhang GY; Jin GZ
    Acta Pharmacol Sin; 2000 Feb; 21(2):145-50. PubMed ID: 11263261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs.
    Snell LD; Johnson KM
    J Pharmacol Exp Ther; 1986 Sep; 238(3):938-46. PubMed ID: 2875174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrically-evoked dopamine and acetylcholine release from rat striatal slices perfused without magnesium: regulation by glutamate acting on NMDA receptors.
    Jin S; Fredholm BB
    Br J Pharmacol; 1997 Aug; 121(7):1269-76. PubMed ID: 9257903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices.
    Jin S; Johansson B; Fredholm BB
    J Pharmacol Exp Ther; 1993 Nov; 267(2):801-8. PubMed ID: 7902434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine transporter mediated release of dopamine: role of chloride.
    Sitges M; Reyes A; Chiu LM
    J Neurosci Res; 1994 Sep; 39(1):11-22. PubMed ID: 7807588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phorbol esters and D2-dopamine receptors.
    Cubeddu LX; Lovenberg TW; Hoffman IS; Talmaciu RK
    J Pharmacol Exp Ther; 1989 Nov; 251(2):687-93. PubMed ID: 2530340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative dopamine-cholinergic mechanisms in the olfactory tubercle and the striatum: effects of metoclopramide.
    Suarez-Roca H; Lovenberg T; Cubeddu LX
    J Pharmacol Exp Ther; 1987 Dec; 243(3):840-51. PubMed ID: 3320346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum.
    Blandina P; Goldfarb J; Craddock-Royal B; Green JP
    J Pharmacol Exp Ther; 1989 Dec; 251(3):803-9. PubMed ID: 2600815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 2-adrenoceptors are not involved in the regulation of striatal glutamate release: comparison to dopaminergic inhibition.
    Harsing LG; Vizi ES
    J Neurosci Res; 1991 Mar; 28(3):376-81. PubMed ID: 1677428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal tachykinin gene expression regulated by interaction of D-1 and D-2 dopamine receptors.
    Haverstick DM; Rubenstein A; Bannon MJ
    J Pharmacol Exp Ther; 1989 Feb; 248(2):858-62. PubMed ID: 2521903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regulation of (-)-sulpiride-induced increase in evoked dopamine release from striatal slices in rat].
    Yamada S; Yokoo H; Nishi S
    Yakubutsu Seishin Kodo; 1992 Aug; 12(4):193-7. PubMed ID: 1414037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus.
    Luccini E; Musante V; Neri E; Raiteri M; Pittaluga A
    J Neurosci Res; 2007 Dec; 85(16):3657-65. PubMed ID: 17671992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D2-dopamine receptor-mediated inhibition of cyclic AMP formation in striatal neurons in primary culture.
    Weiss S; Sebben M; Garcia-Sainz JA; Bockaert J
    Mol Pharmacol; 1985 Jun; 27(6):595-9. PubMed ID: 2987658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.